Are you familiar with the new cancer drugs that the FDA has approved within the last year? Gain an introduction to these novel treatments while learning helpful tips to help you quickly grasp drug classifications. Presenter Teresa Knoop, MSN, RN, AOCN®, CCRP, will walk you through the multidisciplinary trends in drug development, discuss the newly approved molecular and radiotherapeutic agents, and share future directions for cancer therapies.
OBJECTIVES1. Identify new drugs that have been FDA-approved for cancer treatment in 2013 and 2014.
2. Recognize how new drugs are given generic names.
3. Identify how to gain information about new drugs based on the generic naming system.
ILNA
This session qualifies for the following ONCC Individual Learning Needs Assessment (ILNA) categories.
OCN®: Scientific Basis for Practice, Treatment Modalities
CBCN®: Treatment Modalities: Local and Systemic, Professional Performance
AOCNP®: Cancer Treatment
AOCNS®: Cancer Treatment
